# Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer

> **NCT01707641** · PHASE4 · UNKNOWN · sponsor: **S. Andrea Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Mucositis

## Interventions

- **DIETARY_SUPPLEMENT:** CD#2
- **OTHER:** bicarbonate sodium mouthwash

## Key facts

- **NCT ID:** NCT01707641
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2014-12
- **Final completion:** 2019-12
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01707641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01707641, "Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01707641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*